HHS diverts $40M to immigration crisis under Trump policy

President Donald Trump’s policy of “zero tolerance” on illegal immigration has led HHS to redirect millions in funding to house migrant children separated from their parents at the border.

Announced in May, the policy, which Trump halted June 20 via executive order, was met with backlash after images and sounds of crying children in federal detention centers were brought to light.

Prior to gaining media attention, HHS officials planned to direct $263 million to house migrant children separated from their parents, according to a draft document signed by HHS Secretary Alex Azar. The transfer of funds was never made as a result of the heightened scrutiny over the issue.

The agency has diverted at least $40 million over the past two months to care for and reunify migrant children separated from their families, Politico reported. Housing costs are estimated at $1.5 million per day.

Critics argue that the immigration policy is creating undue financial burdens that could pivot resources from critical health programs and research.

“The agency has dipped into nearly $200 million in funds that were initially steered to the refugee office in the waning days of the Obama administration, including at least $17 million in unspent funds on the Ryan White HIV/AIDS program,” Politico reported, noting the funds were originally moved under the Obama administration due to unpredictable border pressures.

One of the major drivers of the high cost of caring for the migrant children is the quick pace in which shelters are needed as a result of a surge of children separated from their families, according to Politico. More than 2,500 children were separated since May, costing more than $30 million in care and housing, Politico reported.  

HHS spent $10 million to hire 100 additional case managers and roughly 50 support staff as the agency and the Department of Homeland Security have scrambled to meet a court-mandated deadline to reunite children with their families.

HHS has made other significant budget decisions recently, including terminating a widely-used clinical database of best practices known as the National Guideline Clearinghouse.

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.